3rd CNS Anticancer Drug Discovery and Development Conference
The 3rd CNS Anticancer Drug Discovery and Development Conference will be held November 14-15, 2018 just prior to the SNO Annual Meeting in New Orleans. A world-class program has been developed that will provide an educational venue for scientists, clinicians, and regulatory decision-makers to better understand the special requirements for effective anticancer therapies for the treatment of primary infiltrative gliomas, medulloblastoma, and metastatic tumors to the CNS.